Cullinan Therapeutics

CAMBRIDGE, Massachusetts, United States — October 27, 2026 Cullinan Therapeutics, Inc., a clinical-stage biopharmaceutical company developing potential first- or...

San Mateo, California, August 12, 2026 Mendaera Inc. announced results from a new peer-reviewed prospective multispecialty study showing that...

Brisbane, California, August 12, 2026 Freenome, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough...

Princeton, New Jersey, Tokyo, Japan & Cambridge, Massachusetts, August 12, 2026 Taiho Oncology, Taiho Pharmaceutical, and Cullinan Therapeutics announced...

CAMBRIDGE, Mass., July 28, 2026 Cullinan Therapeutics announced positive feedback from the U.S. Food and Drug Administration (FDA) following...

PRINCETON, NJ — November 20 , 2025 — Taiho Oncology, Taiho Pharmaceutical, and Cullinan Therapeutics announced the initiation of...